Who owns COGNITION THERAPEUTICS INC?
- Ticker: CGTX
- CUSIP Number: 19243b102
Tip: Access positions for across all investors
Analyze quarterly positions in Cognition Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cognition Therapeutics stock
Who bought or sold COGNITION THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.1M | $1.9M | 25% | Jun 2024 |
|
| Alyeska Investment Group | 500k | $234k | 0% | Sep 2024 |
|
| Geode Capital Management | 324k | $152k | 32% | Sep 2024 |
|
| CM Management | 250k | $117k | 25% | Sep 2024 |
|
| American Financial Group | 205k | $96k | 0% | Sep 2024 |
|
| Sigma Planning | 197k | $92k | 15% | Sep 2024 |
|
| Kestra Advisory Services | 188k | $88k | 0% | Sep 2024 |
|
| BlackRock | 156k | $73k | 100% | Sep 2024 |
|
| BlackRock | 153k | $253k | 173% | Jun 2024 |
|
| Acadian Asset Management | 141k | $64k | 100% | Sep 2024 |
|
| Mercer Global Advisors | 96k | $159k | 33% | Jun 2024 |
|
| Commonwealth Equity Services | 91k | $42k | 0% | Sep 2024 |
|
| Renaissance Technologies | 89k | $42k | -1% | Sep 2024 |
|
| Bridgeway Capital Management | 77k | $127k | 0% | Jun 2024 |
|
| State Street Corporation | 63k | $104k | 24% | Jun 2024 |
|
| Virtu Financial | 57k | $27k | 100% | Sep 2024 |
|
| Texas Capital Bank Wealth Management Services | 55k | $92k | 0% | Jun 2024 |
|
| Fca Corp | 52k | $24k | 0% | Sep 2024 |
|
| Circle Wealth Management | 49k | $23k | 0% | Sep 2024 |
|
| Northern Trust | 48k | $22k | 0% | Sep 2024 |
|
| Castle Wealth Management | 43k | $20k | 0% | Sep 2024 |
|
| Bangor Savings Bank | 34k | $16k | 0% | Sep 2024 |
|
| Northeast Financial Consultants | 25k | $12k | 0% | Sep 2024 |
|
| Tocqueville Asset Management | 24k | $11k | -41% | Sep 2024 |
|
| HighTower Advisors | 23k | $38k | 0% | Jun 2024 |
|
| Jane Street | 23k | $11k | 100% | Sep 2024 |
|
| Gratus Capital | 18k | $31k | 0% | Jun 2024 |
|
| Bessemer | 14k | $6.0k | 100% | Sep 2024 |
|
| Smith Anglin Financial | 12k | $5.6k | 0% | Sep 2024 |
|
| Tower Research Capital | 11k | $18k | 66% | Jun 2024 |
|
| Raymond James & Associates | 10k | $4.7k | 0% | Sep 2024 |
|
| Northwestern Mutual Wealth Management Company | 5.9k | $2.7k | 0% | Sep 2024 |
|
| Bank of America Corporation | 5.3k | $2.5k | 1% | Sep 2024 |
|
| Morgan Stanley | 3.0k | $5.0k | 0% | Jun 2024 |
|
| Ariel Capital Advisors | 2.3k | $1.1k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 1.8k | $846.000000 | 55% | Sep 2024 |
|
| Wells Fargo & Company | 1.0k | $469.000000 | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 78.00 | $37.003200 | 100% | Sep 2024 |
|
Who sold out of Cognition Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AWM Investment Company | Jun 2024 | 650k | $1.1M |
| Timelo Investment Management | Mar 2024 | 481k | $875k |
| AIGH Capital Management | Jun 2024 | 301k | $499k |
| Corsair Capital Management | Mar 2024 | 285k | $519k |
| Carlson Capital | Jun 2024 | 140k | $232k |
| Envestnet Asset Management | Jun 2024 | 30k | $50k |
| Citadel Advisors | Jun 2024 | 27k | $45k |
| Millennium Management | Jun 2024 | 14k | $23k |
| Charles Schwab Investment Management | Jun 2024 | 12k | $20k |
| Susquehanna International | Jun 2024 | 10k | $17k |
| Qube Research & Technologies | Mar 2024 | 2.1k | $3.9k |
| Sandy Spring Bank | Jun 2024 | 2.0k | $3.3k |
| Opal Wealth Advisors | Jun 2024 | 500.00 | $830.000000 |
| Royal Bank of Canada | Jun 2024 | 338.00 | $1.0k |